EWTX Price Prediction Next Week
Analysis and Insights
Technical Analysis:
EWTX is currently trading at $26.43 with a 2.96% increase during the regular market on March 17, 2025. The stock is approaching a resistance level of $29.13, as indicated by Fibonacci analysis, while support is at $24.39. The RSI_14 is at 45.33, suggesting the stock is not overbought, and the MACD is slightly bearish at -0.27. The Stochastic Oscillator indicates the stock is in the lower range, suggesting potential oversold conditions.
News and Analyst Sentiment:
Analysts maintain a Strong Buy consensus on EWTX, with a price target of $47.43, indicating an 81% upside potential. Recent insider activity shows negative sentiment, with increased selling, including a notable sale by the CMO. However, upcoming data readouts and a promising pipeline reinforce the Buy rating.
Conclusion:
Based on the analysis, the stock is expected to reach $29.20 in the next trading week. The recommendation is to Buy EWTX.
EWTX Similar Chart Price Prediction
The price of EWTX is predicted to go up 7.35%, based on the high correlation periods with VICR. The similarity of these two price pattern on the periods is 91.58%.
EWTX
VICR
Up: 7.35%Similarity: 91.58%
EWTX Revenue Forecast
EWTX EPS Forecast
EWTX Analyst's Forecast
James Condulis
Stifel
Hold
2025-01-22
Price Target
$30
Upside
+10.54%
Stifel initiated coverage of Edgewise Therapeutics with a Hold rating and $30 price target. The firm says that while Edgewise has "very interesting science" with two clinical-stage assets, its thesis reflects a view that clinical data for both EDG-7500 and sevasemten are early, and there remains "real risk" to the "target-product-profile" for each. The window to clearly differentiate from aficamten is narrow and the path to doing so "is tricky," the analyst tells investors in a research note.
Cory Kasimov
Evercore ISI Group
Buy
2024-12-17
Price Target
$45 → $50
Upside
+65.73%
Srikripa Devarakonda
Truist Securities
Strong Buy
2024-11-27
Price Target
$33 → $50
Upside
+55.28%
